Hara H - Search Results

1

Annatto prevents retinal degeneration induced by endoplasmic reticulum stress in vitro and in vivo.

Tsuruma K, Shimazaki H, Nakashima K, Yamauchi M, Sugitani S, Shimazawa M, Iinuma M, Hara H. Tsuruma K, et al. Among authors: hara h. Mol Nutr Food Res. 2012 May;56(5):713-24. doi: 10.1002/mnfr.201100607. Mol Nutr Food Res. 2012. PMID: 22648618

2

[The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].

Fujishima Y, Hara H, Shimazawa M, Yokota K, Sukamoto T. Fujishima Y, et al. Among authors: hara h. Nihon Yakurigaku Zasshi. 1994 Jul;104(1):19-29. doi: 10.1254/fpj.104.19. Nihon Yakurigaku Zasshi. 1994. PMID: 8076888 Japanese.

3

Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.

Hara H, Yokota K, Shimazawa M, Sukamoto T. Hara H, et al. Jpn J Pharmacol. 1993 Apr;61(4):361-5. doi: 10.1254/jjp.61.361. Jpn J Pharmacol. 1993. PMID: 8100595 Free article.

4

Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models.

Taniguchi T, Shimazawa M, Hara H. Taniguchi T, et al. Among authors: hara h. Brain Res. 2004 Jul 9;1013(2):241-8. doi: 10.1016/j.brainres.2004.04.023. Brain Res. 2004. PMID: 15193534

5

Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.

Hara H, Toriu N, Shimazawa M. Hara H, et al. Cardiovasc Drug Rev. 2004 Fall;22(3):199-214. doi: 10.1111/j.1527-3466.2004.tb00141.x. Cardiovasc Drug Rev. 2004. PMID: 15492768 Review.

6

Comparison of the therapeutic indexes of different molecular forms of botulinum toxin type A.

Yoneda S, Shimazawa M, Kato M, Nonoyama A, Torii Y, Nishino H, Sugimoto N, Kozaki S, Hara H. Yoneda S, et al. Among authors: hara h. Eur J Pharmacol. 2005 Jan 31;508(1-3):223-9. doi: 10.1016/j.ejphar.2004.12.007. Epub 2005 Jan 11. Eur J Pharmacol. 2005. PMID: 15680275

7

Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage.

Morimoto N, Shimazawa M, Yamashima T, Nagai H, Hara H. Morimoto N, et al. Among authors: hara h. Brain Res. 2005 May 17;1044(1):8-15. doi: 10.1016/j.brainres.2005.02.062. Epub 2005 Apr 13. Brain Res. 2005. PMID: 15862784

8

Bunazosin, a selective alpha1-adrenoceptor antagonist, as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.

Hara H, Ichikawa M, Oku H, Shimazawa M, Araie M. Hara H, et al. Cardiovasc Drug Rev. 2005 Spring;23(1):43-56. doi: 10.1111/j.1527-3466.2005.tb00156.x. Cardiovasc Drug Rev. 2005. PMID: 15867947 Review.

9

Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage.

Shimazawa M, Chikamatsu S, Morimoto N, Mishima S, Nagai H, Hara H. Shimazawa M, et al. Among authors: hara h. Evid Based Complement Alternat Med. 2005 Jun;2(2):201-207. doi: 10.1093/ecam/neh078. Epub 2005 Apr 13. Evid Based Complement Alternat Med. 2005. PMID: 15937561 Free PMC article.

10

Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage.

Shimazawa M, Yamashima T, Agarwal N, Hara H. Shimazawa M, et al. Among authors: hara h. Brain Res. 2005 Aug 16;1053(1-2):185-94. doi: 10.1016/j.brainres.2005.06.053. Brain Res. 2005. PMID: 16051195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,792 results

Search Page

Filters